Investor Complains About The WSJ's Obsession With Theranos
Theranos has voided two years of blood tests, faced federal probes, had its founder banned from owning or operating a lab for two years, and is being sued by one of its biggest investors.
And yet, Draper Fisher Jurvetson, the first firm to put in money into the company helmed by Elizabeth Holmes, thinks that the press' attention to Theranos has been overkill.
"I sort of wonder why this is such a big deal for the Wall Street Journal," Steve Jurvetson, a partner at DFJ, said onstage at the Wall Street Journal Digital Conference on Tuesday.
And yet, Draper Fisher Jurvetson, the first firm to put in money into the company helmed by Elizabeth Holmes, thinks that the press' attention to Theranos has been overkill.
"I sort of wonder why this is such a big deal for the Wall Street Journal," Steve Jurvetson, a partner at DFJ, said onstage at the Wall Street Journal Digital Conference on Tuesday.